EPM2AIP1 antibody (C-Term)
Quick Overview for EPM2AIP1 antibody (C-Term) (ABIN5672140)
Target
See all EPM2AIP1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Sequence
- EKAFSYLTRN QHTLSQPLTD EHLQALFRVA TTEMEPGWDD LVRERNESNP
-
Purification
- Affinity purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the C terminal region of human EPM2AIP1
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- EPM2AIP1 (EPM2A (Laforin) Interacting Protein 1 (EPM2AIP1))
-
Alternative Name
- EPM2AIP1
-
Background
-
The EPM2A gene, which encodes laforin, is mutated in an autosomal recessive form of adolescent progressive myoclonus epilepsy. The protein encoded by this gene binds to laforin, but its function is not known. This gene is intronless.
Protein Size: 607 -
Gene ID
- 9852
-
NCBI Accession
- NM_014805, NP_055620
-
UniProt
- Q7L775
Target
-